Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) LT-Debt-to-Total-Asset : 0.00 (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Pharmedic Pharmaceutical Medicinal Joint Stock Company's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Pharmedic Pharmaceutical Medicinal Joint Stock Company LT-Debt-to-Total-Asset Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company LT-Debt-to-Total-Asset Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data

Trend

LT-Debt-to-Total-Asset

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data

LT-Debt-to-Total-Asset

Pharmedic Pharmaceutical Medicinal Joint Stock Company LT-Debt-to-Total-Asset Calculation

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )	=	Long-Term Debt & Capital Lease Obligation (A: . 20 )	/	Total Assets (A: . 20 )
	=		/
	=

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )	=	Long-Term Debt & Capital Lease Obligation (Q: . 20 )	/	Total Assets (Q: . 20 )
	=		/
	=

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Pharmedic Pharmaceutical Medicinal Joint Stock Company LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM

Website

https://www.pharmedic.com.vn

Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010